| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | +11.4% |
| Cost of Revenue | $6.0M | +26.6% |
| Gross Profit | -$3.1M | -46.0% |
| R&D Expense | $6.8M | -40.2% |
| SG&A Expense | $11.5M | -33.0% |
| Operating Income | -$23.3M | +29.7% |
| Interest Expense | $2K | +0.0% |
| Pre-tax Income | -$22.9M | +30.7% |
| Net Income | -$22.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.1M | -43.5% |
| Short-term Investments | $9.8M | — |
| Accounts Receivable | $510K | -47.4% |
| Inventory | $970K | -74.1% |
| Current Assets | $51.9M | -31.8% |
| Total Assets | $55.0M | -29.6% |
| Current Liabilities | $2.2M | -41.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | +29.7% |
| Capital Expenditures | $1.6M | +195.3% |
| Investing Cash Flow | -$11.3M | -1788.1% |
| Financing Cash Flow | $59.9M | +0.0% |
| Free Cash Flow | -$20.3M | +25.2% |
| +30.7% |
| EPS (Basic) | -$0.62 | +34.0% |
| Total Liabilities |
| $2.9M |
| -37.7% |
| Stockholders' Equity | $52.1M | -29.1% |